Alexion Pharmaceuticals Inc. (ALXN) Completes Acquisition of Enobia Pharma
2/7/2012 8:21:01 AM
More...
|
Alexion Pharmaceuticals Inc. (ALXN) to Host Conference Call This Morning to Discuss Company’s Proposed Acquisition of Enobia Pharma
12/29/2011 6:01:50 AM
More...
|
Alexion Pharmaceuticals Inc. (ALXN) to Pay $1 Billion for Enobia Pharma
12/29/2011 6:00:20 AM
More...
|
Enobia Pharma Raises US $40 Million
8/10/2011 6:34:39 AM
More...
|
Lonza Inc. Signs Commercial Manufacturing Deal with Enobia Pharma for Orphan Drug Candidate
3/15/2011 9:07:07 AM
More...
|
Enobia Pharma Announces Completion of Enrollment in Third Phase II Hypophosphatasia Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy
2/24/2011 10:09:19 AM
More...
|
Enobia Pharma Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy
1/11/2011 7:03:23 AM
More...
|
Enobia Pharma Reports Positive Results For Phase II Trial of ENB-0040 in Juvenile Hypophosphatasia
9/24/2010 8:42:01 AM
More...
|
Enobia Pharma Provides Update on Progress With ENB-0040, a Bone-Targeted Enzyme Replacement Therapy for Hypophosphatasia
9/8/2010 12:14:50 PM
More...
|
Enobia Pharma: ENB-0040, a Bone Targeted Enzyme Replacement Therapy, Shows Promise in Children with Hypophosphatasia
6/21/2010 10:03:06 AM
More...
|
|